QUENTIN N. BURDICK, North Dakota EDWARD M. KENNEDY, Massachusetts MARLOW W. COOK, Kentucky ROMAN L. HRUSKA, Nebraska HIRAM L. FONG, Hawaii CHARLES MCC. MATHIAS, JR., Maryland MATHEA FALCO, Staff Director and Chief Counsel (II) CONTENTS Baumgold, Julie, contributing editor, New York Magazine.--. Daroff, Les, panel of former methaqualone abusers (accompanied by Pat, Max R. Poynton, Paul Keel, and Gary Doby) Doby, Gary, panel of former methaqualone abusers (accompanied by Les Daroff, Pat, Max R. Poynton, and Paul Keel). Eckman, John W., president and chief executive officer, William H. Rorer, Inc., Fort Washington, Pa. (accompanied by Dr. Nelson H. Reavey- Cantwell and Thomas E. Quay) - French, Jr., Glendon E., executive vice president and chief administrative officer, Arnar-Stone Laboratories, Inc. (accompanied by Richard D. Manthei), Mount Prospect, Ill.. Gardner, Dr. Elmer A., Director, Division of Neuropharmacological Drug Products, Food and Drug Administration (accompanied Sherwin Gardner, Sherwin, Acting Commissioner of Food and Drugs, Food and Drug Administration (accompanied by John Jennings, Elmer Gardner, Peter Barton Hutt, and Gerald F. Meyer), Washington, D.C... Gay, George R., M.D., F.A.C.A., director of clinical activities, Haight- Ashbury Free Medical Clinic, San Francisco, Calif.. Gilbert, Gerald E., counsel, Hogan and Hartson, for Parke, Davis & Co., Detroit, Mich. (accompanied Dr. Leslie M. Lueck) - Hutt, Peter Barton, General Counsel, Food and Drug Division, Food and Page Inaba, Darryl S., Pharm D., chief pharmaceutical services drug detoxifi- cation, rehabilitation and aftercare project of the Haight-Ashbury Free Medical Clinic, San Francisco, Calif. (accompanied Dr. George Gay)... 188b Inciardi, Dr James A., associate professor, Division of Addiction Sciences, Department of Psychiatry, University of Miami School of Medicine, Miami, Fla.; associate director of research, metropolitan Dade County (Fla.) comprehensive drug program, and senior associate, resource Planning Corp., Washington, D.C., Miami, Fla. Jennings, Dr. John, Associate Commissioner for Medical Affairs, Food and Kunnes, Dr. Richard, psychiatrist, Medical School faculty, University of Michigan, and director, University of Michigan-Washtenaw County Community Mental Health Center's outpatient program, Ann Arbor, Lents, Charles, director of regulatory affairs, Parke, Davis & Co., Detroit, Lueck, Dr. Leslie M., vice president, quality control and government regu- lations, Parke, Davis & Co., Detroit, Mich. (accompanied by Charles Manthei, Richard D., secretary and counsel, Arnar-Stone Laboratories, Inc., Mount Prospect, Ill. (accompanied Glendon E. French, Jr.)-- Meyer, Gerald F., Director, Office of Legislative Services, Food and Drug McMurray, Raymond D., counsel for Cooper Laboratories, Inc., Bedford O'Neill, Dr. Robert C., executive vice president, Cooper Laboratories, Inc., Pat, panel of former methaqualone abusers (accompanied Les Daroff, Poynton, Max R., panel of former methaqualone abusers (accompanied Pat, Page 254 254 77 77 Quay, Thomas E., general counsel, William H. Rorer, Inc., Fort Washington, Pa. (accompanied John W. Eckman). 264 Reavey-Cantwell, Dr. Nelson H., associate professor of medicine, Jefferson 264 Schnoll, Dr. Sidney, Department of Pharmacology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pa.. 89 ALPHABETICAL LIST OF ORGANIZATIONS REPRESENTED Arnar-Stone Laboratories, Inc., Mount Prospect, Ill 301 254 Food and Drug Administration, Department of Health, Education and 150 Haight-Ashbury Free Medical Clinic, San Francisco, Calif. 188b Jefferson Medical College, Department of Pharmacology, Thomas Jefferson University, Philadelphia, Pa. 89 New York Magazine, New York, N. Y.. 115 Panel of former Methaqualone Abusers, Washington, D.C.. 77 Parke, Davis & Company, Detroit, Mich. 233 Rorer, William H., Inc., Fort Washington, Pa 264 University of Miami School of Medicine, Division of Addiction Sciences, 105 University of Michigan, Medical School... 138 CHRONOLOGICAL LIST OF WITNESSES MARCH 28, 1973 Daroff, Les, Pat, Max R. Poynton, Paul Keel, and Gary Doby, panel of Schnoll, Dr. Sidney, Department of Pharmacology, Jefferson Medical Col- Baumgold, Julie, contributing editor, New York Magazine, New York, N. Y.. Gardner, Sherwin, acting commissioner of food and drugs, the Food and Gay, Dr. George, F.A.C.A., director of clinical activities, Haight-Ashbury Lueck, Dr. Leslie, vice president, quality control and government regula- O'Neill, Dr. Robert C., executive Vice president, Cooper Laboratories, Inc., 150 188b 233 254 APRIL 6, 1973 Eckman, John W., president and chief executive officer, William H. Rorer, LIST OF EXHIBITS 1. Text of Senate Resolution 56, section 12, 93d Congress, first session, dated February 27, 1973, authorizing expenditures for the subcommittee to investigate juvenile delinquency. 2. Text of Public Law 91-513, 91st Congress, H.R. 18583, dated October 27, 1970, the "Comprehensive Drug Abuse Prevention and Control Act of 1970". 3. Text of S. 1252, the "Methaqualone Control Act of 1973," dated March 15, 1973, 93d Congress, 1st session, introduced by Hon. Birch Bayh... 4. Statement submitted by Hon. Roman L. Hruska, March 28, 1973, U.S. Senator from the State of Nebraska... Page 264 301 6 11 72 74 5. Photograph depicting "Captain Quaalude" T-shirt, submitted by Dr. Sidney Schnoll.. 6. Article, "Down at the Juice Bars," by Julie Baumgold, New York Magazine, December 4, 1972. 7. Article, "The King of the Juice Bars," by Julie Baumgold, New York Magazine, December 11, 1972. 8. Methaqualone: "Summary of Literature Reports of Misuse," and 9. Letter from FDA requesting NIMH advice, February 14, 1973- 11. Paper, "Cheap Thrills On Steep Hills: The Abuse of Methaqualone in 12. Letter to Hon. Birch Bayh, U.S. Senator, from Dr. Darryl S. Inaba, Chief, Pharmaceutical Services Drug Detoxification, Rehabilitation and After Care Project of the Haight-Ashbury Free Medical Clinic, enclosure, entitled, "An Epidemiological Analysis of the Fluctuation of Drug Dependence in Japan," by Dr. Masaaki Kato, The International Journal of the Addictions, 4(4), pp. 591-621, December 1969. 13. Letters submitted by Dr. Leslie M. Lueck, Parke, Davis & Co., supporting additional control for methaqualone, submitted March 29, 1973.... 14. Report, "Telephone Dictations to M. Nye, Re: Methaqualone/ Maryland Schedule IV," submitted by John Eckman, William H. Rorer, Inc., April 16, 1973. 15. Letter to Mary Jolly, editorial director and chief clerk of the subcommittee, from C. H. Tregoe, chief, Division of Drug Control, State of Maryland, November 3, 1972. 16. Package insert "Quaalude" submitted by John Eckman, William H. Rorer, Inc., April 16, 1973.. 17. Letter to Mary Jolly, editorial director and chief clerk of the subcommittee from Thomas E. Quay, general counsel, William H. Rorer, Inc., dated April 16, 1973. 18. Ad, entitled, "For graduate student John R., lying down to sleep was a real eye-opener," Annals of Internal Medicine, July 1972, Quaalude300 (methaqualone) William H. Rorer, Inc., Fort Washington, Pa..... 99 123 130 152 178 182 191 202 242 271 272 288 295 296 19. Ad, entitled, "A good morning after a sleep-through night," Quaalude300 (methaqualone), William H. Rorer, Inc., Fort Washington, Pa., Psychiatric News, August 18, 1971, pages 8-9.. 20. Letter to C. H. Tregoe, chief, Division of Drug Control, State of Maryland, from John F. Zaroslinski, Ph.D., vice president, research and development, Arnar-Stone Laboratories, Inc., October 24, 1972.. 21. Photographs depicting counterfeit and authentic Arnar-Stone methaqualone, submitted by Glendon E. French, Jr., Arnar-Stone Laboratories, Inc., April 6, 1973.. Page 299 300 305 |